Defective suppressor function in CD4+CD25+ T-cells from patients with type 1 diabetes

Diabetes

Volumn 54, Issue 1, 2005, Pages 92-99

  Lindley, Shelley ^a   Dayan, Colin M ^b   Bishop, Amanda ^b   Roep, Bart O ^c   Peatman, Mark ^a   Tree, Timothy I M ^a,d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD69 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CELL POPULATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME SYNTHESIS; HUMAN; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION; SUPPRESSOR CELL; T LYMPHOCYTE;

ADULT; ANTIGENS, CD; ANTIGENS, CD4; ANTIGENS, DIFFERENTIATION; CD4-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; RECEPTORS, INTERLEUKIN-2; REFERENCE VALUES; T-LYMPHOCYTES, REGULATORY;

EID: 12144249838     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.1.92     Document Type: Article

References (44)

1. Castano L, Eisenbarth GS: Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 8:647-679, 1990
2. Bonifacio E, Bingley PJ: Islet autoantibodies and their use in predicting insulin-dependent diabetes. Acta Diabetol 34:185-193, 1997
3. Atkinson MA, Kaufman DL, Campbell L, Gibbs KA, Shah SC, Bu DF, Erlander MG, Tobin AJ, Maclaren NK: Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339:458-459, 1992
4. Naquet P, Ellis J, Tibensky D, Kenshole A, Singh B, Hodges R, Delovitch TL: T-cell autoreactivity to insulin in diabetic and related non-diabetic individuals. J Immunol 140:2569-2578, 1988
5. Hawkes CJ, Schloot NC, Marks J, Willemen SJ, Drijfhout JW, Mayer EK, Christie MR, Roep BO: T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes. Diabetes 49:356-366, 2000
6. Roep BO: The role of T-cells in the pathogenesis of type 1 diabetes: from cause to cure. Diabetologia 46:305-321, 2003
7. Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, Donaldson D, Gitelman SE, Harlan DM, Xu D, Zivin RA, Bluestone JA: Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 346:1692-1698, 2002
8. Feutren G, Papoz L, Assan R, Vialettes B, Karsenty G, Vexiau P, Du Rostu H, Rodier M, Sirmai J, Lallemand A, et al.: Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset: results of a multicentre double-blind trial. Lancet 2:119-124, 1986
9. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D: Projection of an immunological self shadow within the thymus by the aire protein. Science 298:1395-1401, 2002
10. Leiter EH, Serreze DV: Antigen presenting cells and the immunogenetics of autoimmune diabetes in NOD mice. Reg Immunol 4:263-273, 1992
11. von Herrath MG: Regulation of virally induced autoimmunity and immunopathology: contribution of LCMV transgenic models to understanding autoimmune insulin-dependent diabetes mellitus. Curr Top Microbiol Immunol 263:145-175, 2002
12. Walker LS, Abbas AK: The enemy within: keeping self-reactive T-cells at bay in the periphery. Nat Rev Immunol 2:11-19, 2002
13. Francois Bach J: Regulatory T-cells under scrutiny. Nat Rev Immunol 3:189-198, 2003
14. Shevach EM: CD4+ CD25+ suppressor T-cells: more questions than answers. Nat Rev Immunol 2:389-400, 2002
15. Chatenoud L, Salomon B, Bluestone JA: Suppressor T-cells - they're back and critical for regulation of autoimmunity! Immunol Rev 182:149-163, 2001
16. Sakaguchi S: Regulatory T-cells: key controllers of immunologic self-tolerance. Cell 101:455-458, 2000
17. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH: Identification and functional characterization of human CD4(+)CD25(+) T-cells with regulatory properties isolated from peripheral blood. J Exp Med 193:1285-1294, 2001
18. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G: Ex vivo isolation and characterization of CD4(+)CD25(+) T-cells with regulatory properties from human blood. J Exp Med 193:1303-1310, 2001
19. Levings MK, Sangregorio R, Roncarolo MG: Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T-cell proliferation and can be expanded in vitro without loss of function. J Exp Med 193:1295-1302, 2001
20. Ng WF, Duggan PJ, Ponchel F, Matarese G, Lombardi G, Edwards AD, Isaacs JD, Lechler RI: Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T-cells. Blood 98:2736-2744, 2001
21. Piccirillo CA, Shevach EM: Cutting edge: control of CD8+ T-cell activation by CD4+CD25+ immunoregulatory cells. J Immunol 167:1137-1140, 2001
22. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA: Loss of functional suppression by CD4+CD25+ regulatory T-cells in patients with multiple sclerosis. J Exp Med 199:971-979, 2004
23. Kriegel MA, Lohmann T, Gabler C, Blank N, Kalden JR, Lorenz HM: Defective suppressor function of human CD4+ CD25+ regulatory T-cells in autoimmune polyglandular syndrome type II. J Exp Med 199:1285-1291, 2004
24. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
25. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA: CD4+CD25 high regulatory cells in human peripheral blood. J Immunol 167:1245-1253, 2001
26. Baecher-Allan C, Viglietta V, Hafler DA: Inhibition of human CD4(+) CD25(+high) regulatory T-cell function. J Immunol 169:6210-6217, 2002
27. Egen JG, Allison JP: Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 16:23-35, 2002
28. Egen JG, Kuhns MS, Allison JP: CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 3:611-618, 2002
29. Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K: CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 82:143-146, 1997
30. Maurer M, Loserth S, Kolb-Maurer A, Ponath A, Wiese S, Kruse N, Rieckmann P: A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) altersll T-cell activation. Immunogenetics 54:1-8, 2002
31. Waldmann TA: The interleukin-2 receptor. J Biol Chem 266:2681-2684, 1991
32. De Berardinis P, Londei M, Kahan M, Balsano F, Kontiainen S, Gale EA, Bottazzo GF, Feldmann M: The majority of the activated T-cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4+. Clin Exp Immunol 73:255-259, 1988
33. Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K, Ten S, Sanz M, Exley M, Wilson B, Porcelli S, Maclaren N: Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 109:131-140, 2002
34. Stephens LA, Mottet C, Mason D, Powrie F: Human CD4(+)CD25(+) thymocytes and peripheral T-cells have immune suppressive activity in vitro. Eur J Immunol 31:1247-1254, 2001
35. Arif S, Tree TI, Astill TP, Tremble JM, Bishop AJ, Dayan CM, Roep BO, Peakman M: Autoreactive T-cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest 113:451-463, 2004
36. Alleva DG, Crowe PD, Jin L, Kwok WW, Ling N, Gottschalk M, Conlon PJ, Gottlieb PA, Putnam AL, Gaur A: A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J Clin Invest 107:173-180, 2001
37. Kotani R, Nagata M, Moriyama H, Nakayama M, Yamada K, Chowdhury SA, Chakrabarty S, Jin Z, Yasuda H, Yokono K: Detection of GAD65-reactive T-cells in type 1 diabetes by immunoglobulin-free ELISPOT assays. Diabetes Care 25:1390-1397, 2002
38. Gessl A, Waldhausl W: Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing. J Clin Endocrinol Metab 83:2204-2209, 1998
39. Arva E, Andersson B: Kinetics of cytokine release and expression of lymphocyte cell-surface activation markers after in vitro stimulation of human peripheral blood mononuclear cells with Streptococcus pneumoniae. Scand J Immunol 49:237-243, 1999
40. Linsley PS, Greene JL, Tan P, Bradshaw J, Ledbetter JA, Anasetti C, Damle NK: Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J Exp Med 176:1595-1604, 1992
41. van der Merwe PA, Bodian DL, Daenke S, Linsley P, Davis SJ: CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J Exp Med 185:393-403, 1997
42. Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, Thompson CB, Bluestone JA: CTLA-4 can function as a negative regulator of T-cell activation. Immunity 1:405-413, 1994
43. Read S, Powrie F: CD4(+) regulatory T-cells. Curr Opin Immunol 13:644-649, 2001
44. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC: Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506-511, 2003